CARGO Therapeutics

News

Concentra throws lifeline to troubled CARGO Therapeutics

After cutting staff and halting development of its CAR-T therapies, CARGO has agreed to a takeover by Kevin Tang's Concentra Bio.

News

CARGO offloads staff after abandoning lead CAR-T

Less than 18 months after its IPO, CAR-T developer CARGO has abandoned its development efforts and slashed around 90% of its staff.

News

CARGO eyes $300m IPO against lacklustre listings backdrop

CARGO Therapeutics has said it plans to offer around 18.8 million shares in the latest bid by a biotech to list on the Nasdaq, amid a desultory year for initial public off

Concentra throws lifeline to troubled CARGO Therapeutics

CARGO offloads staff after abandoning lead CAR-T

CARGO eyes $300m IPO against lacklustre listings backdrop

Regenxbio, Solid report data with Duchenne gene therapies

Using AI-driven synthetic personas to take your insights fur...

Editor's Picks